[Skip to Content]
[Skip to Content Landing]
Citations 0
Correspondence
May 1999

Sézary Syndrome, Cutaneous T-Cell Lymphoma, and Extracorporeal Photopheresis—Reply

Author Affiliations

Not Available

Arch Dermatol. 1999;135(5):601. doi:10-1001/pubs.Arch Dermatol.-ISSN-0003-987x-135-5-dlt0599

In reply

Edelson suggests that prior treatment with chemotherapy might explain the failure of ECP treatment to affect survival in our patients with Sézary syndrome (SS). In fact, only 4 patients had been treated with high-dose chemotherapy such as fludarabine or pentostatin prior to starting ECP therapy. Most had received phototherapy (16 patients) or low-dose oral chemotherapy with chlorambucil (16 patients). This is still a popular first-line therapy with many dermatologists, and it seems highly likely that other studies of ECP also included patients who had been similarly pretreated. Indeed, in Edelson's original study,1 28 of 37 patients had received systemic chemotherapy prior to ECP.

First Page Preview View Large
First page PDF preview
First page PDF preview
×